Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Newly described activating JAK3 mutations in T-cell acute lymphoblastic leukemia

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Flex E, Petrangeli V, Stella L, Chiaretti S, Hornakova T, Knoops L et al. Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia. J Exp Med 2008; 205: 751–758.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Mullighan CG, Zhang J, Harvey RC, Collins-Underwood JR, Schulman BA, Phillips LA et al. JAK mutations in high-risk childhood acute lymphoblastic leukemia. Proc Nat Acad Sci USA 2009; 106: 9414–9418.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Gaikwad A, Rye CL, Devidas M, Heerema NA, Carroll AJ, Izraeli S et al. Prevalence and clinical correlates of JAK2 mutations in Down syndrome acute lymphoblastic leukaemia. Br J Haematol 2009; 144: 930–932.

    Article  CAS  PubMed  Google Scholar 

  4. Jeong EG, Kim MS, Nam HK, Min CK, Lee S, Chung YJ et al. Somatic mutations of JAK1 and JAK3 in acute leukemias and solid cancers. Clin Cancer Res 2008; 14: 3716–3721.

    Article  CAS  PubMed  Google Scholar 

  5. Kameda T, Shide K, Shimoda HK, Hidaka T, Kubuki Y, Katayose K et al. Absence of gain-of-function JAK1 and JAK3 mutations in adult T cell leukemia/lymphoma. Int J Hematol 2010; 92: 320–325.

    Article  CAS  PubMed  Google Scholar 

  6. Cornejo MG, Kharas MG, Werneck MB, Le Bras S, Moore SA, Ball B et al. Constitutive JAK3 activation induces lymphoproliferative syndromes in murine bone marrow transplantation models. Blood 2009; 113: 2746–2754.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Walters DK, Mercher T, Gu TL, O'Hare T, Tyner JW, Loriaux M et al. Activating alleles of JAK3 in acute megakaryoblastic leukemia. Cancer Cell 2006; 10: 65–75.

    Article  CAS  PubMed  Google Scholar 

  8. Beadling C, Heinrich MC, Warrick A, Forbes EM, Nelson D, Justusson E et al. Multiplex mutation screening by mass spectrometry evaluation of 820 cases from a personalized cancer medicine registry. J Mol Diagn 2011; 13: 504–513.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Shochat C, Tal N, Bandapalli OR, Palmi C, Ganmore I, te Kronnie G et al. Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias. J Exp Med 2011; 208: 901–908.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Zenatti PP, Ribeiro D, Li W, Zuurbier L, Silva MC, Paganin M et al. Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia. Nat Genet 2011; 43: 932–939.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Hornakova T, Chiaretti S, Lemaire MM, Foà R, Ben Abdelali R, Asnafi V et al. ALL-associated JAK1 mutations confer hypersensitivity to the antiproliferative effect of type I interferon. Blood 2010; 115: 3287–3295.

    Article  CAS  PubMed  Google Scholar 

  12. Malinge S, Ragu C, Della-Valle V, Pisani D, Constantinescu SN, Perez C et al. Activating mutations in human acute megakaryoblastic leukemia. Blood 2008; 112: 4220–4226.

    Article  CAS  PubMed  Google Scholar 

  13. Sato T, Toki T, Kanezaki R, Xu G, Terui K, Kanegane H et al. Functional analysis of JAK3 mutations in transient myeloproliferative disorder and acute megakaryoblastic leukaemia accompanying Down syndrome. Br J Haematol 2008; 141: 681–688.

    Article  CAS  PubMed  Google Scholar 

  14. Haan C, Rolvering C, Raulf F, Kapp M, Drückes P, Thomas G et al. Jak1 has a dominant role over Jak3 in signal transduction through γc-containing cytokine receptors. Chem Biol 2011; 18: 314–323.

    Article  CAS  PubMed  Google Scholar 

  15. Changelian PS, Moshinsky D, Kuhn CF, Flanagan ME, Munchhof MJ, Harris TM et al. The specificity of JAK3 kinase inhibitors. Blood 2008; 111: 2155–2157.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G Fan.

Ethics declarations

Competing interests

Michael Heinrich has equity interest in and is a consultant for Molecular MD. The other authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bains, T., Heinrich, M., Loriaux, M. et al. Newly described activating JAK3 mutations in T-cell acute lymphoblastic leukemia. Leukemia 26, 2144–2146 (2012). https://doi.org/10.1038/leu.2012.74

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2012.74

This article is cited by

Search

Quick links